Market research
0690.HK Uni-Bio Science Group Limited
HK HKD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 424M
- P/E ratio
- 7.1
- Analyst target
- Not available
- Dividend yield
- 4.2%
- Beta
- -0.07
Profile
Company facts
- Exchange
- HK
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- KYG9198H1406
- Market cap
- 424M
- P/E ratio
- 7.1
- Analyst target
- Not available
- Dividend yield
- 4.2%
- Beta
- -0.07
About
About Uni-Bio Science Group Limited
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People's Republic of China. It operates through Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products segments. The company provides BOGUTAI, a disposable injection pen for the treatment of osteoporosis; GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat invasive aspergillosis and fungal infections; and Boshutai, for treating osteoporosis and bone pain. It also offers medical aesthetics. Uni-Bio Science Group Limited was incorporated in 2001 and is headquartered in Sha Tin, Hong Kong.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 0690.HK discussion.
5 years, 5 months ago
Uni-Bio Science Group Limited is currently in a long term downtrend where the price is trading 5.9% below its 200 day moving average.
From a valuation standpoint, the stock is 96.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Uni-Bio Science Group Limited's total revenue sank by 39.9% to $67M since the same quarter in the previous year.
Its net income has increased by 73.0% to $-11M since the same quarter in the previous year.
Finally, its free cash flow grew by 162.0% to $5M since the same quarter in the previous year.
Based on the above factors, Uni-Bio Science Group Limited gets an overall score of 3/5.